Sequence 3 from Patent EP2108658

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

Myelin-reactive B cells exacerbate CD4(+) T cell-driven CNS autoimmunity in an IL-23-dependent manner. [Nat Commun. 2024]
Myelin-reactive B cells exacerbate CD4(+) T cell-driven CNS autoimmunity in an IL-23-dependent manner.
Fazazi MR, Doss PMIA, Pereira R, Fudge N, Regmi A, Joly-Beauparlant C, Akbar I, Yeola AP, Mailhot B, Baillargeon J, et al. Nat Commun. 2024 Jun 26; 15(1):5404. Epub 2024 Jun 26.
CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation. [Nature. 2024]
CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation.
Ahmed A, Joseph AM, Zhou J, Horn V, Uddin J, Lyu M, Goc J, JRI Live Cell Bank, Sockolow RE, Wing JB, et al. Nature. 2024 Jun; 630(8018):976-983. Epub 2024 Jun 12.
Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axis. [Int Immunopharmacol. 2024]
Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axis.
Chen L, Huang D, Huang Z, Liu X, He M, Luo M, Tang Z, Tan G, Guo Q, Xiong H. Int Immunopharmacol. 2024 May 30; 133:112033. Epub 2024 Apr 11.

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide